Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company\'s shares
Shaanxi Panlong Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Shaanxi Panlong Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Shaanxi Panlong Pharmaceutical: Announcement on the First Share Repurchase and Progress Update of Share Repurchase.
Shaanxi Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company's shares
Shaanxi Panlong Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice
Shaanxi Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company's shares
Shaanxi Panlong Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
Panlong Pharmaceutical: An indicative announcement on the listing and circulation of some restricted shares issued to specific targets
Panlong Pharmaceutical: Announcement on the progress of the repurchase of the company's shares
Panlong Pharmaceutical: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Panlong Pharmaceutical: Repurchase Report
Panlong Pharmaceutical: Announcement on the plan to repurchase the company's shares through centralized bidding
Panlong Pharmaceutical: Reminder Notice on Receiving Proposals from the Company\'s Controlling Shareholders, Actual Controllers, and Chairman of the Board to Repurchase the Company\'s Shares
Panlong Pharmaceutical: Announcement on passively diluting the shareholding ratio of controlling shareholders and actual controllers by more than 1%
Panlong Pharmaceutical: Panlong Pharmaceutical\'s listing announcement to issue shares to specific targets in 2023 (summary)
Panlong Pharmaceutical: listing sponsorship letter from Zhongtai Securities Co., Ltd. regarding the issuance of A-shares by Shaanxi Panlong Pharmaceutical Group Co., Ltd. to specific targets
No Data